Treatment of suppurative facial cellulitis and panniculitis caused by Corynebacterium pseudotuberculosis in two horses

Journal of the American Veterinary Medical Association

Volumn 224, Issue 7, 2004, Pages 1139-1142+1112

  Farstvedt, Ellis G ^a   Hendrickson, Dean A ^a   Dickenson, Charles E ^a   Spier, Sharon J ^b  

^a Department of Ecosystem Science and Sustainability   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTIOFUR; COTRIMOXAZOLE; ENROFLOXACIN; GENTAMICIN; OXACILLIN; PHENYLBUTAZONE; POLY(HEXAMETHYLENEBIGUANIDE); PROCAINE PENICILLIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TICARCILLIN;

ABSCESS; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; CELLULITIS; CLINICAL FEATURE; CORYNEBACTERIUM; DISEASE COURSE; FEMALE; HORSE; NONHUMAN; PANNICULITIS; REVIEW; WOUND CARE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CELLULITIS; COMBINED MODALITY THERAPY; CORYNEBACTERIUM INFECTIONS; CORYNEBACTERIUM PSEUDOTUBERCULOSIS; DEBRIDEMENT; FEMALE; HORSE DISEASES; HORSES; MALE; PANNICULITIS; TREATMENT OUTCOME; WOUND HEALING;

ANIMALIA; CORYNEBACTERIUM; CORYNEBACTERIUM PSEUDOTUBERCULOSIS; EQUIDAE; EQUUS CABALLUS;

EID: 1642441756     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.1139     Document Type: Review

References (27)

1. Doherr MG, Carpenter TE, Hanson KMP, et al. Risk factors associated with Corynebacterium pseudotuberculosis infection in California horses. Prev Vet Med 1998;35:229-239.
2. Aleman M, Spier SJ, Wilson WD, et al. Corynebacterium pseudotuberculosis infection in horses: 538 cases (1982-1993). J Am Vet Med Assoc 1996;209:804-809.
3. Miers KC, Ley WB. Corynebacterium pseudotuberculosis infection in the horse: study of 117 clinical cases and consideration of etiopathogenesis. J Am Vet Med Assoc 1980;177:250-253.
4. Welsh RD. Corynebacterium pseudotuberculosis in the horse. Equine Pract 1990;12:7-16.
5. Hall K, McCluskey BJ, Cunningham W. Corynebacterium pseudotuberculosis infections (pigeon fever) in horses in western Colorado: an epidemiological investigation. J Equine Vet Pract 2001; 21:284-286.
6. Menzies PI, Muckle CA, Hwang YT, et al. The evaluation of an enzyme-linked immunosorbant assay using Escherichia coli recombinant phospholipase D antigen for the diagnosis of Cornyebacterium pseudotuberculosis infection, in Proceedings. Am Dairy Goat Assoc Natl Conv 1993;13-20.
7. Carne HR, Onon EO. Action of Corynebacterium ovis exotoxin on endothelial cells of blood vessels. Nature 1978;271: 246-248.
8. Yozwiak ML, Songer JG. Effect of Corynebacterium pseudotuberculosis phospholipase D on viability and chemotactic responses of ovine neutrophils. Am J Vet Res 1993;54:392-397.
9. Biberstein EL, Knight HD, Jang S. Two biotypes of Corynebacterium pseudotuberculosis. Vet Rec 1971;62:135-143.
10. Costa LRR, Spier SJ, Hirsh DC. Comparative molecular characterization of Corynebacterium pseudotuberculosis of different origin. Vet Microbiol 1998;62:135-143.
11. Songer JG, Beckenbach K, Marshall MM, et al. Biochemical and genetic characterization of Corynebacterium pseudotuberculosis. Am J Vet Res 1988;49:223-226.
12. Adamson PJ, Wilson WD, Hirsch DC, et al. Susceptibility of equine bacterial isolates to antimicrobial agents. Am J Vet Res 1985; 46:447-450.
13. Judson R, Songer JG. Corynebacterium pseudotuberculosis: in vitro susceptibility to 39 antimicrobial agents. Vet Microbiol 1991; 27:145-150.
14. Stashak T. Selected factors that affect wound healing. In: Equine wound management. Philadelphia: Lea & Febiger, 1991;19-35.
15. Jones V, Harding K. Moist wound healing. In: Chronic wound care: a clinical source book for healthcare professionals. Malvern, Pa: HMP Communications, 2001;245-252.
16. Dolynchuk KN. Debridement. In: Chronic wound care: a clinical source book for healthcare professionals. Malvern, Pa: HMP Communications, 2001;385-397.
17. Katz MH, Alvarez AF, Kirsner RS, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 1991;25:1054-1058.
18. Turner TD. The development of wound management products. In: Chronic wound care: a clinical source book for healthcare professionals. Malvern, Pa: HMP Communications, 2001;293-310.
19. Komarcevic A. The modern approach to wound treatment. Med Pregl 2000;53:363-368.
20. Kunimoto BT. Growth factors in wound healing. In: Chronic wound care: a clinical source book for healthcare professionals. Malvern, Pa: HMP Communications, 2001;391-397.
21. Hendrickson DA. Equine advanced wound care and bandaging for the veterinarian [book on CD-ROM]. Fort Collins, Colo: Colorado Stare University, 2002.
22. Doyle JW, Roth TP, Smith RM, et al. Effects of calciurn alginate on cellular wound healing processes modeled in vitro. J Biomed Mater Res 1996;32:561-568.
23. Lansdown AB. Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen 2002;10;271-285.
24. Rodeheaver GT. Wound cleansing, wound irrigation, wound disinfection. In: Chronic wound care: a clinical source book for healthcare professionals. Malvern, Pa: HMP Communications, 2001; 369-383.
25. Wright RW Jr, Ort R. Fibroblast cytotoxicity and blood cell integrity following exposure to dermal wound cleansers. Ostomy Wound Manage 1993;39:33-40.
26. Angelique MR, Rodeheaver GT. Effectiveness of a new antimicrobial gauze dressing as a bacterial barrier [pamphlet]. Mansfield, Mass: Tyco Health Care Group, 2001.
27. Davis S, Mertz P, Cazzaniga A, et al. The use of a new antimicrobial gauze dressing: effects on the rate of epithelization of partial thickness wounds [pamphlet]. Mansfield, Mass: Tyco Health Care Group, 2000.